Fibrin sealant does not decrease seroma output or time to drain removal following inguino-femoral lymph node dissection in melanoma patients: A randomized controlled trial (NCT00506311)
2008

Fibrin Sealant and Drain Removal in Melanoma Surgery

Sample size: 30 publication Evidence: low

Author Information

Author(s): Melinda M Mortenson, Yan Xing, Storm Weaver, Jeffrey E Lee, Jeffrey E Gershenwald, Anthony Lucci, Paul F Mansfield, Merrick I Ross, Janice N Cormier

Primary Institution: The University of Texas M. D. Anderson Cancer Center

Hypothesis

Applying a fibrin sealant during inguino-femoral lymph node dissection will decrease the time to drain removal and reduce postoperative complications.

Conclusion

Using a fibrin sealant during surgery did not reduce the time to drain removal or complications for melanoma patients.

Supporting Evidence

  • Patients reported significant discomfort and difficulties with daily activities due to drains.
  • The median time to drain removal was similar between the fibrin sealant group and the control group.
  • No significant differences in complications were observed between the two groups.

Takeaway

Doctors tested a special glue to see if it could help patients heal faster after surgery, but it didn't work as they hoped.

Methodology

Patients were randomized to receive either a fibrin sealant or no sealant during surgery, and outcomes were compared.

Potential Biases

Potential bias due to the single-institution setting and small sample size.

Limitations

The study was small with only 30 patients, which may limit the generalizability of the results.

Participant Demographics

Median age was 56.3 years, with equal male and female representation in the pilot study.

Statistical Information

P-Value

0.6

Statistical Significance

p=0.6

Digital Object Identifier (DOI)

10.1186/1477-7819-6-63

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication